FACTUAL CIRCUMSTANCES Sample Clauses
The 'Factual Circumstances' clause defines the specific facts and background information that both parties agree are true and relevant to the contract. This clause typically outlines the context in which the agreement is made, such as the parties' prior dealings, the existence of certain conditions, or the occurrence of particular events. By clearly stating these agreed-upon facts, the clause helps prevent future disputes over the underlying assumptions of the contract and ensures that both parties have a shared understanding of the circumstances influencing their obligations.
FACTUAL CIRCUMSTANCES. Respondent reported at the time of her 2010 renewal of her social work license that she had completed the required continuing education according to Board guidelines, when she had not.
FACTUAL CIRCUMSTANCES. 3. The Board received an application for a psychologist license from Applicant.
4. Applicant disclosed that her license to practice psychology in Minnesota is currently suspended due to a Stipulation and Consent Order adopted by the Minnesota Board of Psychology on June 26, 2020.
5. The suspension of Applicant’s Minnesota psychologist license stemmed from a pattern of failure to complete evaluation reports in a timely manner and providing the Minnesota Board with false information indicating that her evaluation reports were up-to-date.
FACTUAL CIRCUMSTANCES. Respondent's pharmacist license number 19563 is currently activethrough June 30, 2023.
FACTUAL CIRCUMSTANCES. 2. The Board received an application for a pharmacist license from Applicant.
3. In 2014, ▇▇▇▇▇▇▇▇▇’s Kentucky pharmacist license was suspended as a result of being terminated from her employer for diversion of controlled substances and Applicant’s admission that she was addicted to oxycodone. Applicant’s Kentucky pharmacist license was reinstated in September 2016 and placed on probation for a period of ten years, subject to several terms, including participation in Kentucky’s Pharmacist Recovery Network. Applicant’s Kentucky pharmacist license is currently on probation, which is expected to last until September 2026.
FACTUAL CIRCUMSTANCES. 1. Respondent’s pharmacy license number 1128 is currently active through December 31, 2022.
2. Respondent’s CSA registration number 1107653 is currently active through May 31, 2024.
3. In response to a complaint, ▇▇▇▇▇▇▇▇▇▇ underwent an inspection in December 2021.
4. During the inspection, the Board compliance officer observed inadequate staffing. Respondent has experienced high staff turnover.
5. During the inspection, three different schedule II controlled substances were counted, and all three showed discrepancies between the perpetual inventory and the actual on-hand inventory.
6. Respondent had a permanent pharmacist in charge vacate the position on or around March 9, 2021. The Board did not receive notification of the temporary PIC who was appointed on or around March 10, 2021, and did not receive an application naming a new permanent pharmacist in charge until on or around December 27, 2021. Respondent was unable to readily retrieve a record showing that the required controlled substances inventory was completed on March 9, 2021.
7. During the week of January 17, 2022, Respondent was intermittently closed during regular business hours due to the lack of pharmacist coverage. When the pharmacy was able to find coverage and be open, the pharmacists were unable to transfer prescriptions when requested by patients. As a result, some patients were unable to access their medications.
FACTUAL CIRCUMSTANCES. 1. Respondent’s nonresident pharmacy license number 4635 is currently active through December 31, 2022.
2. Respondent’s CSA registration number 1108761 is currently active through January 31, 2024.
3. In April 2021, a Board compliance officer purchased tretinoin cream 0.1% from Respondent using the option on Respondent’s website for a prescriber to provide a prescription for the selected product. The Board compliance officer submitted an online questionnaire and submitted a photo of a baby doll to complete the questionnaire.
4. In May 2021, a Board compliance officer purchased a compounded product consisting of tadalafil and horny goat weed from Respondent using the option on Respondent’s website for a prescriber to provide a prescription for the selected product. The Board compliance officer submitted an online questionnaire.
5. In both instances, the Board compliance officer was not contacted by the prescriber after submission of the online questionnaire and had no interaction with the prescriber. During the on-site inspection described below, it was observed that, when performing the required prospective drug use review for a prescription, the pharmacist had access to any comments or patient interactions documented by the prescriber. There were no comments or patient interactions documented by the prescriber for the two prescriptions. (Count I)
6. In both instances, the Board compliance officer received the prescription without being provided oral counseling by Respondent in advance of receipt. (Count II)
7. The prescription label for the compounded product consisting of tadalafil and horny goat weed was missing the date the preparation was compounded, the beyond-use date, the statement “Compounded Preparation,” and batch identification. (Count III)
8. Respondent’s compounding records indicated the tadalafil powder used to compound the product consisting of tadalafil and horny goat weed on March 24, 2021, had expired on January 31, 2021. Respondent’s compounding log did not indicate who had performed the compounding steps. (Count IV)
9. On or around July 26-27, 2021, an on-site inspection was conducted by two Board compliance officers, during which numerous deficiencies were identified. The deficiencies are fully set forth in the inspection report, which is hereby incorporated by reference. (Count IV, V)